The usefulness of acetyl-l-carnitine in polyneuropathy treatment and prevention was assessed by several studies [70,71,72,73,74,75,76,77] (Table 2)
* * * * * (f) * * * (1) * * * (i) * * * (A) Is approved by one of the national organizations listed in 415.152 of this chapter, provided that the national organization does not use accreditation criteria that promote or encourage discrimination on the basis of race, color, national origin, sex, age, disability, or religion, including the use of those characteristics or intentional proxies for those characteristics as a selection criterion for employment, program participation, resource allocation, or similar activities, opportunities, or benefits
Children aged 12 years and older with obesity (injection only at this time)
large human trials are not yet